| GIL Deadline News: Gildan Investors are Notified of the Imminent December 14 Securities Fraud Class Action – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:33 |
| BAC Deadline News: Bank of America Investors are Notified of the Imminent December 15 Securities Fraud Class Action – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:33 |
| MDLN Investigation News: Medline Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:33 |
| FUN Investigation News: Six Flags Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:33 |
| ENSG Deadline News: Ensign Group Investors are Notified of the Imminent December 7 Securities Fraud Class Action – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:33 |
| ALHC Investigation News: Alignment Healthcare Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:33 |
| CDNL Investigation News: Cardinal Infrastructure Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:33 |
| TTAN Investigation News: ServiceTitan Investors are Notified of the Pending Securities Fraud Investigation – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:33 |
| GOOG, GOOGL Deadline News: Alphabet Investors are Notified of the Imminent December 1 Securities Fraud Class Action – Contact BFA Law if You Lost Money |
Globe Newswire |
10/23 |
06:32 |
| Tango Presents Promising Results from Phase 1/2 Study of Vopimetostat and Daraxonrasib in Pancreatic Cancer and Provides Updates to Development Strategy |
Globe Newswire |
10/23 |
06:30 |
| John Legend on Pharrell’s musical push, Jay-Z’s praise and new creative challenges with ‘Muse’ |
AP Online |
10/23 |
06:27 |
| Why big music stars like Harry Styles and Celine Dion are embracing residencies |
AP Online |
10/23 |
06:08 |
| Zymeworks Enters into an Exclusive Global License and Collaboration Agreement with Roche for ZW209, a Trispecific T cell Engager Targeting DLL3 |
Globe Newswire |
10/23 |
06:00 |
| WellerPCB Publishes New Engineering Guides on PCB Material Selection, Fine-Pitch BGA Design, and High-Voltage Insulation |
Globe Newswire |
10/23 |
05:03 |
| WeShop Opens Share Claims for UK Members on November 23, Marking One Year on Nasdaq |
Globe Newswire |
10/23 |
05:00 |
| MISSION SUCCESS: Rocket Lab Launches 98th Electron Mission |
Globe Newswire |
10/23 |
04:47 |
| US Treasury proposes a rule to crack down on high-tech investments in China, other adversaries |
AP Online |
10/23 |
04:29 |
| From nearshore waters to the deep blue: China's Fuzhou charts a new course in maritime strength |
Globe Newswire |
10/23 |
04:23 |
| Correction: Norsk Hydro: Solid results and strong performance |
Globe Newswire |
10/23 |
04:21 |
| BankWells Highlights Digital Financial Services for Personal and Business Money Management |
Globe Newswire |
10/23 |
04:17 |
| UN climate fund promises $20 million for Nepal flood recovery, far short of billions needed |
AP Online |
10/23 |
04:05 |
| Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA |
Globe Newswire |
10/23 |
04:00 |
| ORIC® Pharmaceuticals Presents Potential Best-in-Class Data for Enozertinib in 1L NSCLC Patients with EGFR Atypical Mutations at ESMO Congress 2026 and Plans to Advance Enozertinib into a Global Phase 3 Trial |
Globe Newswire |
10/23 |
03:15 |
| ORIC® Pharmaceuticals Presents Preclinical and Translational Data to Support the Potential of Rinzimetostat to Enhance Sensitivity to Androgen Receptor Inhibition in Prostate Cancer at ESMO Congress 2026 |
Globe Newswire |
10/23 |
03:15 |
| Solidgate Secures MiCA Authorization as a Crypto-Asset Service Provider |
Globe Newswire |
10/23 |
03:00 |
